Science and technology company Merck has opened a new packaging facility at its biotech manufacturing site in Aubonne, Switzerland.

The new building will be used for visual inspection and packaging processes, as well as shipping the company’s biotech medicines to more than 150 countries.

The facility will also enable Merck to carry out ongoing and future product launches.

Merck executive board chairman and CEO Stefan Oschmann said: “This state-of-the-art new packaging building demonstrates Merck's technological leadership in biotech manufacturing.

“With Aubonne and nearby Vevey, Switzerland is our prime hub for the manufacturing of biotech medicines for patients all over the world. It plays an instrumental role in the growth of our Healthcare business sector and the launch of new products.”

The new building is equipped with fully automated machinery and robotised logistics, which will allow it to process more than 12 million boxes of medicine and four million injection devices annually.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"This state-of-the-art new packaging building demonstrates Merck's technological leadership in biotech manufacturing."

Merck noted that the facility is designed to adhere to international quality, environment, health and safety standards.

Since 2015, the company has invested nearly CHF27m ($28m) in the facility's construction.

The building is one of a series of investments by Merck over the past ten years in Switzerland, which amounts to more than CHF1bn ($1.04bn).

The company currently employs around 2,000 people across its 11 locations in the country, which include more than 700 in Aubonne.

Image: Merck officials during the inauguration ceremony of the new packaging building at Swiss Biotech Manufacturing Site of Aubonne. Photo: courtesy of PRNewsfoto / Merck.